Logo image
IRO Home Research units Researcher Profiles
Sign in
Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients
Journal article   Peer reviewed

Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients

Vikas Y Sacher, Debra Fertel, Karan Srivastava, Anthony Panos, Dao Nguyen, Tammy Baxter, Shirin Shafazand and Si M Pham
The Annals of thoracic surgery, Vol.97(1), pp.268-274
01/2014
DOI: 10.1016/j.athoracsur.2013.07.072
PMID: 24119986

View Online

Abstract

Follow-Up Studies Immunosuppression - methods Humans Immunosuppressive Agents - therapeutic use Middle Aged Postoperative Complications - prevention & control Male Dose-Response Relationship, Drug Adult Female Retrospective Studies Sirolimus - adverse effects Sirolimus - therapeutic use Drug Administration Schedule Lung Transplantation - mortality Bronchiolitis Obliterans - etiology Graft Rejection - prevention & control Survival Rate Treatment Outcome Lung Transplantation - adverse effects Syndrome Bronchiolitis Obliterans - prevention & control Primary Prevention - methods Immunosuppressive Agents - adverse effects Lung Transplantation - methods Graft Survival - drug effects Cohort Studies

Details

Logo image